In the univariate analyses, significant difference was found between DVT and non-DVT groups in term of BMI (24.4 ± 3.7 kg/m2 vs 23.2 ± 3.4 kg/m2), prevalence rate of peripheral vascular disease (8.6% vs 2.9%) and a history of a VTE event (13.3% vs 4.5%), time from injury to DVT screening (7.7 ± 4.5d vs 3.6 ± 3.3d) platelet count > 214*109/L (53.3% vs 38.8%), HCT < 34% (80.0% vs 66.9%), D-Dimer level > 1.0 mg/L (78.1% vs 62.0%), PLR > 174 (67.6% vs 51.7%), albumin level < 32.5 g/L (62.9% vs 41.3%) and TC < 3.45 mmol/L (49.5% vs 35.1%). The gene discussed is ALB; the disease is peripheral vascular disease.